Moderna and ROVI Pharma Industrial Services on Friday announced a recall of one lot of Moderna's COVID-19 vaccine Spikevax, consisting of 764,900 doses distributed in several countries in Europe from January 13 to 14. "The lot is being recalled due to a foreign body found in one vial in the lot manufactured at (Moderna's) contract manufacturing site, ROVI, in Spain," Moderna and ROVI said in a statement, adding that the lot was being recalled out of "an abundance of caution". Moderna was alerted to the issue through a product complaint from a vaccination center in Malaga, Spain. The vial was returned for forensic assessment and investigation, it said. Moderna said it had conducted a cumulative search of its global safety database and found no safety concerns in individuals who received a COVID-19 shot from this lot. The lot was distributed in Norway, Poland, Portugal, Spain and Sweden. More than 900M doses of the Moderna COVID-19 vaccine have been administered to date worldwide. MRNA stock closed +1.2% at $160.84 on Friday.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!